| For: | Bartolini I, Nannini G, Risaliti M, Matarazzo F, Moraldi L, Ringressi MN, Taddei A, Amedei A. Impact of microbiota-immunity axis in pancreatic cancer management. World J Gastroenterol 2022; 28(32): 4527-4539 [PMID: 36157926 DOI: 10.3748/wjg.v28.i32.4527] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i32/4527.htm |
| Number | Citing Articles |
| 1 |
Emad Hamdy Gad. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies. 2023; doi: 10.5772/intechopen.111726
|
| 2 |
Sara Fanijavadi, Lars Henrik Jensen. Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes. International Journal of Molecular Sciences 2025; 26(2): 730 doi: 10.3390/ijms26020730
|
| 3 |
Sara Sofia De Lucia, Enrico Celestino Nista, Marcello Candelli, Sebastiano Archilei, Franziska Deutschbein, Enrico Capuano, Antonio Gasbarrini, Francesco Franceschi, Giulia Pignataro. Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components. Cancers 2025; 17(22): 3618 doi: 10.3390/cancers17223618
|
| 4 |
Ying Li, Shini Liu, Xiaorong Lai, Dongyang Yang. Analysis of the predictive effect of gut microbiota changes on the occurrence of chemotherapy resistance in pancreatic cancer patients based on nomogram prediction models. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-15309-z
|
| 5 |
Xuejiao Wei, Fei Wang, Peng Tan, Huiming Huang, Zhuguo Wang, Jinxin Xie, Longyan Wang, Dongxiao Liu, Zhongdong Hu. The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives. Pharmacological Research 2024; 203: 107148 doi: 10.1016/j.phrs.2024.107148
|
| 6 |
Xin Li, Zhihai Liang. Causal effect of gut microbiota on pancreatic cancer: A Mendelian randomization and colocalization study. Journal of Cellular and Molecular Medicine 2024; 28(8) doi: 10.1111/jcmm.18255
|
